Recently, it has been found that the aberrant activation of NLRP3 inflammasome is associated with a variety of diseases, such as metabolic syndrome, neuroinflammation, and inflammatory bowel disease (IBD) (Sharma and Kanneganti 2021). This evidence concerns the gene NLRP3 and inflammatory bowel disease.